Results 61 to 70 of about 10,981,272 (272)
Persistent varices in cured patients: Understanding the role of hepatic venous pressure gradient
Background & Aims: Etiologic factor removal (ER) drives recompensation and improves portal hypertension in cirrhosis. Esophageal varices (EV) and portosystemic shunts (PSS) have been found in patients despite hepatic venous pressure gradient (HVPG ...
Pol Olivas +18 more
doaj +1 more source
Umbilical cord stem cell‐derived exosomes encapsulated in an immunomodulatory bioadhesive hydrogel spray enable localized therapy, sustained vesicle delivery, macrophage polarization, suppress systemic inflammation, and mitigate glucose and insulin homeostasis impairments in MAFLD.
Triya Saha +4 more
wiley +1 more source
Splenic vein stenting for recurrent chylous ascites in sinistral portal hypertension: a case report
Background Sinistral portal hypertension results from obstruction or stenosis of the splenic vein and is characterized by normal portal vein pressures and liver function tests.
Brian Covello +2 more
doaj +1 more source
Endoscopic ultrasound guided portal pressure gradient measurement [PDF]
Portal hypertension is most commonly associated as a complication related to liver cirrhosis. Portal hypertension increases morbidity and mortality usually through gastrointestinal bleeding however other complications such as ascites formation and subsequent spontaneous bacterial peritonitis may occur.
openaire +3 more sources
A Panel of Circulating Exosomal sncRNAs Associated With Lung Cancer Risk up to 10 Years in Advance
Lung cancer is often diagnosed too late, and current screening overlooks many people at risk. In a long‐term study of smokers, a panel of small non‐coding RNAs carried in blood exosomes signals elevated lung cancer risk up to ten years before diagnosis, pointing toward a blood‐based tool for earlier risk detection.
Zhuokun Feng +12 more
wiley +1 more source
Pharmacological therapy of portal hypertensi¢n can be accomplished according to different objectives. Among them, pre-primary prophylaxis aims to avoid / delay esophageal varices development while the target of primary prophylaxis is protection against ...
Julio D. Vorobioff, M.D. +1 more
doaj +1 more source
Hepatic Venous Pressure Gradient: Measurement and Pitfalls. [PDF]
Measurement of hepatic venous pressure gradient (HVPG) effectively mirrors the severity of portal hypertension (PH) and offers valuable insights into prognosis of liver disease, including the risk of decompensation and mortality.
Berzigotti, Annalisa +4 more
core +1 more source
Systematic characterization of the liver‐resident microbiota in advanced metabolic dysfunction‐associated steatotic liver disease (MASLD) reveals a consistent depletion of Bacteroides uniformis (B. uniformis) in both hepatic and gut microbial communities. Oral gavage of B.
Haiyang Liu +4 more
wiley +1 more source
Portal hypertension (PHT) is pivotal in managing decompensated cirrhosis. In clinical practice, hepatic venous collaterals are frequently present, often leading to failure or reduced accuracy of hepatic venous pressure gradient (HVPG) measurements ...
Zhonghua Wang +6 more
doaj +1 more source
Background/Aims: Plug-assisted retrograde transvenous obliteration (PARTO) is widely used to manage gastric varices with a portosystemic shunt. It is not clear whether portal pressure and the incidence of complications increase after PARTO.
Jae Woo Park +12 more
doaj +1 more source

